Literature DB >> 9118693

Laboratory abnormalities in patients with bacterial pneumonia.

R T Sankaran1, J Mattana, S Pollack, P Bhat, T Ahuja, A Patel, P C Singhal.   

Abstract

STUDY
OBJECTIVES: This study was undertaken to evaluate the laboratory abnormalities observed in patients with bacterial pneumonia as predictors of the severity of illness.
DESIGN: Retrospective analysis.
SETTING: Tertiary care hospital. PATIENTS AND PARTICIPANTS: We studied 302 consecutive patients who were admitted to the Long Island Jewish Medical Center from January through December 1993 and treated for bacterial pneumonia. The patients were subdivided into two groups based on their serum phosphorus level either on hospital admission or 4 days before the onset of pneumonia, if this was acquired in-hospital. Hypophosphatemia (group 1) was defined as serum phosphorus level of < or = 2.4 mg/dL and normophosphatemia > 2.4 mg/dL (group 2). Three hundred randomly selected hospitalized patients treated for conditions other than pneumonia comprised the control group (group 3). MEASUREMENTS: Groups 1 and 2 were compared with respect to laboratory data, mortality rate, and duration of hospitalization. The laboratory data of patients in group 3 were compared with those treated for bacterial pneumonia (groups 1 and 2). Stepwise multivariate logistic regression analysis was employed to identify the variables that best predicted the onset of pneumonia.
RESULTS: In groups 1 and 2, a greater (p < 0.0001) number of patients (135 of 302 patients with pneumonia, 44.7%) developed hypophosphatemia compared with patients in group 3 (31 of 300 control subjects, 10.3%). Patients with pneumonia (groups 1 and 2) had higher levels (p < 0.01) of bicarbonate compared with control subjects. Moreover, patients with pneumonia demonstrated lower levels (p < 0.01) of calcium, phosphorus, albumin, cholesterol, and alanine aminotransferase compared with control patients (group 3). Among patients with pneumonia, those with hypophosphatemia (group 1) had significantly lower levels (p < 0.05) of potassium, calcium, and albumin compared to those subjects with normophosphatemia (group 2). Furthermore, hypophosphatemic subjects manifested higher levels of glucose (p < 0.01) and creatine phosphokinase (p < 0.05) compared to their normophosphatemic counterparts. In addition, hypophosphatemic patients experienced a longer duration of hospital stay (hypophosphatemia, 24.6 +/- 2.0 days, vs normophosphatemia, 14.1 +/- 1.0, p < 0.001) and higher (p < 0.001) mortality compared to normophosphatemic subjects. The incidence of nosocomial pneumonia was higher (p < 0.0001) in hypophosphatemic patients compared to those with normophosphatemia.
CONCLUSION: We conclude that hypophosphatemia, hypocalcemia, hypokalemia, and hypoalbuminemia may be predictors of the severity of illness in patients admitted to the hospital with bacterial pneumonia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9118693     DOI: 10.1378/chest.111.3.595

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

1.  Severe pneumonia in the elderly: a multivariate analysis of risk factors.

Authors:  Wei Li; Cheng Ding; Shaojun Yin
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Impaired rehabilitation secondary to muscle weakness induced by meropenem.

Authors:  Leon Margolin
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

3.  Role of arterial blood gas (ABG) as a valuable assessment tool of disease severity in SARS-CoV-2 patients.

Authors:  Jyot Amrita; Arvinder Pal Singh
Journal:  J Med Biochem       Date:  2022-02-02       Impact factor: 2.157

Review 4.  Treatment of hypophosphatemia in the intensive care unit: a review.

Authors:  Daniël A Geerse; Alexander J Bindels; Michael A Kuiper; Arnout N Roos; Peter E Spronk; Marcus J Schultz
Journal:  Crit Care       Date:  2010-08-03       Impact factor: 9.097

5.  Serum Lipoproteins Are Critical for Pulmonary Innate Defense against Staphylococcus aureus Quorum Sensing.

Authors:  Brett C Manifold-Wheeler; Bradley O Elmore; Kathleen D Triplett; Moriah J Castleman; Michael Otto; Pamela R Hall
Journal:  J Immunol       Date:  2015-11-25       Impact factor: 5.422

6.  Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults.

Authors:  Coleman Rotstein; Gerald Evans; Abraham Born; Ronald Grossman; R Bruce Light; Sheldon Magder; Barrie McTaggart; Karl Weiss; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-01       Impact factor: 2.471

7.  Phoxilium(®) reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy.

Authors:  Gabriela Godaly; Ola Carlsson; Marcus Broman
Journal:  Clin Kidney J       Date:  2015-12-19

8.  Fever as a cause of hypophosphatemia in patients with malaria.

Authors:  Warren Browner; Richard Haber
Journal:  PLoS One       Date:  2007-12-26       Impact factor: 3.240

9.  Serum inorganic phosphorus levels predict 30-day mortality in patients with community acquired pneumonia.

Authors:  Mohammad E Naffaa; Mona Mustafa; Mohje Azzam; Roni Nasser; Nizar Andria; Zaher S Azzam; Eyal Braun
Journal:  BMC Infect Dis       Date:  2015-08-13       Impact factor: 3.090

10.  Hyperphosphatemia Is an Independent Risk Factor for Mortality in Critically Ill Patients: Results from a Cross-Sectional Study.

Authors:  Dominik G Haider; Gregor Lindner; Michael Wolzt; Sufian S Ahmad; Thomas Sauter; Alexander Benedikt Leichtle; Georg-Martin Fiedler; Valentin Fuhrmann; Aristomenis K Exadaktylos
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.